{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:10:33Z","timestamp":1761491433878,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.transci.2022.103499","type":"journal-article","created":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T20:19:30Z","timestamp":1656879570000},"page":"103499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Spotlights on the latest opinions on identification, prevention, and management of newer CoV-2 variants: A roundup appraisal on innovative ideas and designer vaccines for Omicron"],"prefix":"10.1016","volume":"61","author":[{"given":"Jerard","family":"Seghatchian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.transci.2022.103499_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102794","article-title":"Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: a rousing message of clinical benefit to both donors and recipients alike","volume":"59","author":"Seghatchian","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"10.1016\/j.transci.2022.103499_bib2","article-title":"Update on newer approaches to prevent or treat COVID-19 infection: What we all need the most right now!!","volume":"59","author":"Seghatchian","year":"2020","journal-title":"TransfusApher Sci"},{"issue":"3","key":"10.1016\/j.transci.2022.103499_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2991\/chi.k.210403.001","article-title":"Therapeutic use of convalescent plasma in COVID-19 infected patients with concomitant hematological disorders","volume":"3","author":"Lanza","year":"2021","journal-title":"Clin Hematol Int"},{"key":"10.1016\/j.transci.2022.103499_bib4","first-page":"1","article-title":"Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation","volume":"11","author":"Brissot","year":"2020","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"10.1016\/j.transci.2022.103499_bib5","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/oxfimm\/iqab006","article-title":"The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role","volume":"2","author":"Bertoletti","year":"2021","journal-title":"Oxf Open Immunol"},{"key":"10.1016\/j.transci.2022.103499_bib6","first-page":"182554","article-title":"T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals","author":"Jordan","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"10.1016\/j.transci.2022.103499_bib7","first-page":"074","article-title":"Passive immunotherapy using approved vaccines combined with lockdown, as essential parts of the community medicine and public health to survive and even beat COVID: a viewpoint commentary","volume":"7","author":"Seghatchian","year":"2021","journal-title":"Arch Community Med Public Health"},{"key":"10.1016\/j.transci.2022.103499_bib8","unstructured":"WHO. Tracking SARS-CoV-2 variants, \u3008https:\/\/www.who.int\/en\/activities\/tracking-SARS-CoV-2-variants\/\u3009; 2021."},{"issue":"5","key":"10.1016\/j.transci.2022.103499_bib9","volume":"60","author":"Seghatchian","year":"2021","journal-title":"TransfusApher Sci"},{"key":"10.1016\/j.transci.2022.103499_bib10","unstructured":"Nature. COVID vaccine boosters: the most important questions, \u3008https:\/\/www.nature.com\/articles\/d41586\u2013021-02158\u20136\u3009; 2021."},{"issue":"10","key":"10.1016\/j.transci.2022.103499_bib11","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1111\/trf.16641","article-title":"Modeling global transfusion medicine education","volume":"31","author":"Sibinga","year":"2021","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.transci.2022.103499_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/0886022X.2020.1764369","article-title":"Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients","volume":"42","author":"Chen","year":"2020","journal-title":"Ren Fail"},{"key":"10.1016\/j.transci.2022.103499_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.thromres.2020.10.025","article-title":"Prothrombotic hemostasis disturbances in patients with severe COVID-19: a prospective longitudinal observational cohort study","volume":"197","author":"Hardy","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.transci.2022.103499_bib14","unstructured":"NHS. COVID treatment developed in the NHS saves a million lives, \u3008https:\/\/www.england.nhs.uk\/2021\/03\/covid-treatment-developed-in-the-nhs-saves-a-million-lives\/\u3009; 2021."},{"key":"10.1016\/j.transci.2022.103499_bib15","unstructured":"GOV.UK Government launches COVID-19 Antivirals Taskforce to roll out innovative home treatments this autumn, \u3008https:\/\/www.gov.uk\/government\/news\/government-launches-covid-19-antivirals-taskforce-to-roll-out-innovative-home-treatments-this-autumn\u3009; 2021 [accessed December 7 2021]."},{"issue":"11","key":"10.1016\/j.transci.2022.103499_bib16","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1021\/acs.jproteome.0c00365","article-title":"Serum proteomics in COVID-19 patients: altered coagulation and complement status as a function of IL-6 level","volume":"19","author":"D\u2019Alessandro","year":"2020","journal-title":"J Proteome"},{"issue":"7","key":"10.1016\/j.transci.2022.103499_bib17","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/jth.14849","article-title":"Thromboinflammation and the hypercoagulability of COVID-19","volume":"18","author":"Connors","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"6556","key":"10.1016\/j.transci.2022.103499_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/science.abh1766","article-title":"Ultra potent antibodies against diverse and highly transmissible CoV-2 variants","volume":"373","author":"Wang","year":"2021","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.transci.2022.103499_bib19","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.3390\/ijms21093330","article-title":"Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern: the fragile balance between infections and autoimmunity","volume":"21","author":"Picchianti Diamanti","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.transci.2022.103499_bib20","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41591-021-01413-7","article-title":"Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals","volume":"27","author":"Kustin","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.transci.2022.103499_bib21","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1038\/s41467-021-22811-y","article-title":"Identification and characterisation of a SARS-CoV-2 specific CD8+ T-cell response with immunodominant features","volume":"12","author":"Gangaev","year":"2021","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.transci.2022.103499_bib22","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/blood.2020007938","article-title":"Post discharge thrombosis and hemorrhage in patients with COVID-19","volume":"136","author":"Patell","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.transci.2022.103499_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102934","article-title":"An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research","volume":"59","author":"Putter","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"6","key":"10.1016\/j.transci.2022.103499_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102985","article-title":"Editorial: An introductory commentary on the use of artificial intelligence, machine learning and TQM, as novel computational tools in big data patterns or procedural analysis, in transfusion medicine","volume":"59","author":"Seghatchian","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2022.103499_bib25","article-title":"Phase I dose-escalation single center clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19. E","volume":"39","author":"P\u00e9rez-Mart\u00ednez","year":"2021","journal-title":"Clin Med"},{"year":"2019","series-title":"Quality control of qualitative tests for medical laboratories","author":"Pereira","key":"10.1016\/j.transci.2022.103499_bib26"},{"key":"10.1016\/j.transci.2022.103499_bib27","unstructured":"Clinical Laboratory Standards Institute. EP12-A2 User protocol for evaluation of qualitative test performance. 2nd ed. Wayne (PA): CLSI."},{"key":"10.1016\/j.transci.2022.103499_bib28","unstructured":"Bettencourt da Silva R., Ellison S.L.R. (eds.). Eurachem\/CITAC Guide: Assessment of performance and uncertainty in qualitative chemical analysis.1st ed. Eurachem, 2021."},{"issue":"2","key":"10.1016\/j.transci.2022.103499_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103093","article-title":"Immunotherapy for COVID-19: evolving treatment of viral infection and associated adverse immunological reactions","volume":"60","author":"Putter","year":"2021","journal-title":"Transfus Apher Sci"},{"issue":"16","key":"10.1016\/j.transci.2022.103499_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150012","article-title":"Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay","volume":"6","author":"Lopez","year":"2021","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.transci.2022.103499_bib31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41392-021-00797-9","article-title":"Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.transci.2022.103499_bib32","article-title":"An overview of current position on cell therapy in transfusion science and medicine: from fictional promises to factual and perspectives from red cell substitution to stem cell therapy","author":"Lanza","year":"2020","journal-title":"TransfusApher Sc"},{"key":"10.1016\/j.transci.2022.103499_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.16814","article-title":"Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID-19 infected patients","author":"Lanza","year":"2020","journal-title":"Br J Haematol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022200180X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022200180X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:54:05Z","timestamp":1761468845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147305022200180X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S147305022200180X"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2022.103499","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spotlights on the latest opinions on identification, prevention, and management of newer CoV-2 variants: A roundup appraisal on innovative ideas and designer vaccines for Omicron","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2022.103499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103499"}}